Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Responsibility versus residence: how will this change in Department of Health policy affect you and your breast screening service?

Authors: M Wheaton, MG Wallis

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

Call and recall mechanisms for women in many areas of the NHSBSP are based on GP practice within the HA of residence. Women are invited to the breast screening service purchased by the HA in which they reside, regardless of responsibility status of their registered GP. With the advent of Primary Care Groups and Primary Care Trusts, the Department of Health is to issue a policy statement from April 1, 2001, requiring all breast screening services to call and recall women registered with GPs responsible to that HA. Our service will lose 4712 and gain 4920 women, a net gain of 208 women. However small the gain, 9632 women will change their screening service causing significant disruption to all concerned. …
Metadata
Title
Responsibility versus residence: how will this change in Department of Health policy affect you and your breast screening service?
Authors
M Wheaton
MG Wallis
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr259

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

A trial of duplicating film for mammography

Meeting abstract

Pictorial essay of fat necrosis

Meeting abstract

Surgical management

Meeting abstract

Introducing MRI into clinical breast practice

Meeting abstract

UK NHSBSP multicentre image guided biopsy trial: an interim analysis

Meeting abstract

Flexible screening clinics: future options
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits